Profile for Lithuania Patent: 2459208
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Lithuania Patent: 2459208
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,377,880 | Jul 29, 2030 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| 8,999,932 | Feb 7, 2031 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| 9,278,995 | Jul 29, 2030 | Kai Pharms Inc | PARSABIV | etelcalcetide |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
